-
Something wrong with this record ?
Increased cardio-ankle vascular index in hyperlipidemic patients without diabetes or hypertension
P. Dobsak, V. Soska, O. Sochor, J. Jarkovsky, M. Novakova, M. Homolka, M. Soucek, P. Palanova, F. Lopez-Jimenez, K. Shirai,
Language English Country Japan
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13434
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Free Medical Journals
from 2002
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - English
from 1994
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - English
from 1994
Open Access Digital Library
from 1994-01-01
Open Access Digital Library
from 2002-01-01
PubMed
25342382
DOI
10.5551/jat.24851
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Hyperlipidemias complications physiopathology MeSH
- Hypertension complications MeSH
- Diabetes Complications physiopathology MeSH
- Ankle blood supply MeSH
- Humans MeSH
- Young Adult MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
AIM: The cardio-ankle vascular index (CAVI) is a sensitive non-invasive marker of arterial stiffness and atherosclerosis. The aim of this work was to compare the CAVI values in patients with dyslipidemia (without diabetes mellitus and hypertension) and healthy controls. METHODS: A Total 248 subjects with dyslipidemia (104 men, 144 women), 55.0 (95% CI 30-70) years of age with combined hyperlipidemia or primary hypercholesterolemia and 537 healthy controls (244 men, 293 women) 40.0 (95% CI 26-62) years of age were included in this study. Fasting blood samples were collected to measure the serum total cholesterol, triglyceride, HDL-cholesterol and apolipoprotein A1 and B levels. The LDL cholesterol level was also calculated, and the CAVI was measured using the VaSera(®) 1500 system. RESULTS: The CAVI values were significantly higher in the dyslipidemic patients (8.08, 95% CI 6.00-10.05) than in the controls (7.11, 95% CI 5.77-9.05; p < 0.01). In addition, the CAVI values were elevated in both subgroups of patients with hypercholesterolemia (7.95, 95% CI 5.85-6.90; p < 0.01) and combined hyperlipidemia (8.30, 95% CI 6.60-10.15; p < 0.01) in comparison with those observed in the controls. After adopting the propensity score method in order to balance the confounding factors (age, gender, body mass index) and adjust the analysis for diastolic blood pressure, the CAVI values in the dyslipidemic patients remained significantly high (7.78, 95% CI 5.80-9.69) compared to that observed in the controls (7.31, 95% CI 5.44-9.35; p < 0.001). However, the CAVI values did not differ significantly between the controls and both subgroups of dyslipidemic patients(primary hypercholesterolemia, combined hyperlipidemia). CONCLUSIONS: The present findings demonstrated that dyslipidemia increases the CAVI values in comparison to that seen in healthy subjects.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000572
- 003
- CZ-PrNML
- 005
- 20190917112706.0
- 007
- ta
- 008
- 160108s2015 ja f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5551/jat.24851 $2 doi
- 035 __
- $a (PubMed)25342382
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ja
- 100 1_
- $a Dobšák, Petr, $u Department of Sports Medicine and Rehabilitation, St. Anne's Faculty Hospital and Masaryk University of Brno, Czech Republic; International Clinical Research Center, Department of Cardiovascular Diseases, St. Anne's University Hospital Brno. Czech Republic. $d 1958- $7 xx0063744
- 245 10
- $a Increased cardio-ankle vascular index in hyperlipidemic patients without diabetes or hypertension / $c P. Dobsak, V. Soska, O. Sochor, J. Jarkovsky, M. Novakova, M. Homolka, M. Soucek, P. Palanova, F. Lopez-Jimenez, K. Shirai,
- 520 9_
- $a AIM: The cardio-ankle vascular index (CAVI) is a sensitive non-invasive marker of arterial stiffness and atherosclerosis. The aim of this work was to compare the CAVI values in patients with dyslipidemia (without diabetes mellitus and hypertension) and healthy controls. METHODS: A Total 248 subjects with dyslipidemia (104 men, 144 women), 55.0 (95% CI 30-70) years of age with combined hyperlipidemia or primary hypercholesterolemia and 537 healthy controls (244 men, 293 women) 40.0 (95% CI 26-62) years of age were included in this study. Fasting blood samples were collected to measure the serum total cholesterol, triglyceride, HDL-cholesterol and apolipoprotein A1 and B levels. The LDL cholesterol level was also calculated, and the CAVI was measured using the VaSera(®) 1500 system. RESULTS: The CAVI values were significantly higher in the dyslipidemic patients (8.08, 95% CI 6.00-10.05) than in the controls (7.11, 95% CI 5.77-9.05; p < 0.01). In addition, the CAVI values were elevated in both subgroups of patients with hypercholesterolemia (7.95, 95% CI 5.85-6.90; p < 0.01) and combined hyperlipidemia (8.30, 95% CI 6.60-10.15; p < 0.01) in comparison with those observed in the controls. After adopting the propensity score method in order to balance the confounding factors (age, gender, body mass index) and adjust the analysis for diastolic blood pressure, the CAVI values in the dyslipidemic patients remained significantly high (7.78, 95% CI 5.80-9.69) compared to that observed in the controls (7.31, 95% CI 5.44-9.35; p < 0.001). However, the CAVI values did not differ significantly between the controls and both subgroups of dyslipidemic patients(primary hypercholesterolemia, combined hyperlipidemia). CONCLUSIONS: The present findings demonstrated that dyslipidemia increases the CAVI values in comparison to that seen in healthy subjects.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a kotník $x krevní zásobení $7 D000842
- 650 _2
- $a komplikace diabetu $x patofyziologie $7 D048909
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperlipidemie $x komplikace $x patofyziologie $7 D006949
- 650 _2
- $a hypertenze $x komplikace $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Soška, Vladimír, $d 1953- $7 nlk20020120980
- 700 1_
- $a Sochor, Ondřej $7 xx0131606
- 700 1_
- $a Jarkovský, Jiří, $d 1976- $7 stk2008461294
- 700 1_
- $a Novakova, Marie
- 700 1_
- $a Homolka, Martin $7 xx0278728
- 700 1_
- $a Souček, Miroslav, $d 1952- $7 xx0001907
- 700 1_
- $a Palanová, Petra $7 xx0137220
- 700 1_
- $a Lopez-Jimenez, Francisco
- 700 1_
- $a Shirai, Kohji
- 773 0_
- $w MED00008313 $t Journal of atherosclerosis and thrombosis $x 1880-3873 $g Roč. 22, č. 3 (2015), s. 272-283
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25342382 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20190917113054 $b ABA008
- 999 __
- $a ok $b bmc $g 1102853 $s 924778
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 22 $c 3 $d 272-283 $e 20141022 $i 1880-3873 $m Journal of atherosclerosis and thrombosis $n J Atheroscler Thromb $x MED00008313
- GRA __
- $a NT13434 $p MZ0
- LZP __
- $a Pubmed-20160108